Recruiting

Familial Carcinoid Tumors

Sponsor:

Rutgers University

Code:

NCT00672269

Conditions

Carcinoid Neuroendocrine Cancer

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

There is a high incidence among the first degree relatives of the carcinoid patients, indicating the involvement of genetic components in its initiation and pathogenesis.

Conditions

Carcinoid Neuroendocrine Cancer

Study ID

NCT00672269

Start date

Apr, 2008

Status verified date

Feb, 2009

Completion date

Jun, 2010

Anticipated

Primary completion date

Apr, 2009

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Over the age of 18 years
2. More than one ,member of a family with a history of biopsy confirmed carcinoid tumor
3. English speaking
4. Mentally and emotionally capable of answering questions
5. Willing and available for study participation
6. At least one other family member with carcinoid tumor

Exclusion Criteria:

1. If you are under the age of 18 years,
2. If you are unable to understand or unable to provide informed consent,
3. If you have a psychological condition (i.e. depression, anxiety disorder, substance abuse, etc.) which might cause you significant problems in dealing with test results.

Study Design

Enrollment

25 participants

Anticipated

Interventions and Outcome Measures

Arms

1

Families with carcinoid in multiple family members

Primary outcome measure

  • Mutations in MEN1 and SDHD genes [ Time Frame: 1 year ]

Central Contacts and Locations

Central contacts

Locations

Busch Campus of Rutgers University, Human Genetics Institute

Recruiting

Piscataway, New Jersey, United States, 08854-8082

Contacts

Principal Investigator:

Changshun Shao, PhD

More Information

Sponsor

Rutgers University

Last update posted

Feb 4, 2009

Last verified

Feb, 2009

Keywords

  • carcinoid
  • family members
  • familial
  • tumors
  • cancer

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Rutgers University on 2009-02-04.